Emergency Physician Urges Heat Safety Ahead of Dangerous Holiday Weekend
Ahead of an extreme heat wave and the Fourth of July holiday, Jamaji Nwanaji-Enwerem, MD, PhD, an assistant professor of Emergency Medicine, reminds Philadelphians that anyone—not just older adults or those with chronic medical conditions—is vulnerable to heat-related illness. He encouraged people to prepare by locating local cooling centers and community resources, staying hydrated before feeling thirsty, wearing protective clothing, and seeking shade whenever possible. Nwanaji-Enwerem emphasized recognizing warning signs of heat stroke, including weakness, confusion, slurred speech, nausea, and unusual behavior, and urged calling 911 immediately if symptoms occur. He also encouraged outdoor workers and holiday revelers to take precautions and prioritize safety.
WGAL8 • PHL17 |
|
|
Can GLP-1s Treat Cancer? What the Latest Science Says About Ozempic’s Newest Benefit
Several recent observational studies indicate that GLP-1 drugs may reduce the risk of some obesity-related cancers. In particular, a Penn Medicine analysis of more than 110,000 women found that those taking GLP-1 medications like Ozempic and Wegovy were roughly 30 percent less likely to develop breast cancer than women who weren’t. Elizabeth McDonald, MD, PhD, a professor of Radiology and practicing breast radiologist in the Abramson Cancer Center, presented the findings at the 2026 ASCO Annual Meeting in June.
U.S. News and World Report • Medical Daily • British Brief |
|
China Approved the World’s First Solid Tumor CAR T Cell Therapy
Last week, China approved the world’s first CAR T cell therapy for solid tumors; the product was developed by a Shanghai-based company to treat advanced gastric cancers. “This will help maintain momentum for the field, which has so much progress with in vivo therapy and autoimmune diseases,” said CAR T cell therapy pioneer Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine. June and Holly Fernandez Lynch, JD, an associate professor of Medical Ethics & Health Policy, also commented on the regulatory hurdles standing in the way of similar cell therapy progress in the U.S.
Fierce Biotech |
|
Next Gen DSM Gets a New Name—and a New Vision
The next edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) will be renamed the Diagnostic and Scientific Manual of Mental Disorders. In addition, the committee overseeing the update is focusing on education and dissemination, research and methodology, the clinical, legal, and social implications of DSM revisions, and the development of a continuously updated “living document.” “We want to integrate all of these elements, and we think AI will be critical in helping us overcome some of the barriers to producing the manual in a more timely and streamlined way,” said Maria Oquendo, MD, PhD, the Ruth Meltzer Professor of Psychiatry and chair of Psychiatry, and chair of the American Psychiatric Association’s Future DSM Strategic Committee.
Medscape |
|
GLP-1 Drugs Like Ozempic Are Now Linked to Smell and Taste Disturbances
New research is linking GLP-1 drugs to another side effect: altering how users smell and taste the world around them. For example, a University of Pennsylvania study found that in a controlled comparison of direct sensory testing, GLP-1 users scored worse on standardized taste tests across all five basic taste qualities: sweet, sour, salty, bitter, and umami.
The Videshi |
|
The Latest on Social Media
|
|
|
